1. Home
  2. BMTX vs RVPH Comparison

BMTX vs RVPH Comparison

Compare BMTX & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMTX
  • RVPH
  • Stock Information
  • Founded
  • BMTX 2015
  • RVPH 2006
  • Country
  • BMTX United States
  • RVPH United States
  • Employees
  • BMTX N/A
  • RVPH N/A
  • Industry
  • BMTX Major Banks
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • BMTX Finance
  • RVPH Health Care
  • Exchange
  • BMTX Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • BMTX 34.6M
  • RVPH 36.4M
  • IPO Year
  • BMTX N/A
  • RVPH N/A
  • Fundamental
  • Price
  • BMTX $3.25
  • RVPH $1.05
  • Analyst Decision
  • BMTX Strong Buy
  • RVPH Strong Buy
  • Analyst Count
  • BMTX 3
  • RVPH 3
  • Target Price
  • BMTX $6.75
  • RVPH $14.33
  • AVG Volume (30 Days)
  • BMTX 48.7K
  • RVPH 179.2K
  • Earning Date
  • BMTX 08-20-2024
  • RVPH 08-12-2024
  • Dividend Yield
  • BMTX N/A
  • RVPH N/A
  • EPS Growth
  • BMTX N/A
  • RVPH N/A
  • EPS
  • BMTX N/A
  • RVPH N/A
  • Revenue
  • BMTX $57,949,000.00
  • RVPH N/A
  • Revenue This Year
  • BMTX $15.52
  • RVPH N/A
  • Revenue Next Year
  • BMTX $5.19
  • RVPH N/A
  • P/E Ratio
  • BMTX N/A
  • RVPH N/A
  • Revenue Growth
  • BMTX N/A
  • RVPH N/A
  • 52 Week Low
  • BMTX $1.41
  • RVPH $1.04
  • 52 Week High
  • BMTX $3.91
  • RVPH $6.80
  • Technical
  • Relative Strength Index (RSI)
  • BMTX 65.67
  • RVPH 31.82
  • Support Level
  • BMTX $2.54
  • RVPH $1.17
  • Resistance Level
  • BMTX $2.89
  • RVPH $1.25
  • Average True Range (ATR)
  • BMTX 0.22
  • RVPH 0.11
  • MACD
  • BMTX 0.10
  • RVPH 0.01
  • Stochastic Oscillator
  • BMTX 100.00
  • RVPH 3.23

About BMTX BM Technologies Inc.

BM Technologies Inc provides digital banking and disbursement services to consumers and students nationwide through a full-service fintech banking platform, accessible to customers anywhere and anytime through digital channels. It facilitates deposits and banking services between a customer and its Partner Bank, Customers Bank, which is a related party and is a Federal Deposit Insurance Corporation (FDIC) insured bank. The company has four primary revenue sources: interchange and card revenue, servicing fees, account fees, and university fees. The majority of revenues are driven by customer activity (deposits, spending, transactions, etc.) and may be paid or passed through by customer banks, universities, or paid directly by customers.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: